Weaver Consulting Group’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Weaver Consulting Group’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-395	Closed	-$4K	–	819
2020 Q3	$4K	Hold	395	–	–	﹤0.01%	747
2020 Q2	$5K	Hold	395	–	–	﹤0.01%	671
2020 Q1	$4K	Hold	395	–	–	﹤0.01%	619
2019 Q4	$3K	Hold	395	–	–	﹤0.01%	706
2019 Q3	$3K	Hold	395	–	–	﹤0.01%	688
2019 Q2	$4K	Hold	395	–	–	﹤0.01%	634
2019 Q1	$4K	Buy	+395	New	+$6.97K	﹤0.01%	1173

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Weaver Consulting Group's TEVA Position: Q4 2020 in Review

Weaver Consulting Group sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2020, closing a stake of 395 shares — an estimated $4K sold.

Weaver Consulting Group first reported a position in TEVA in Q1 2019 and held it in 7 quarters. The position peaked at $5K in Q2 2020. 450 funds tracked by Wall St. Rank hold TEVA as of Q4 2020.

Weaver Consulting Group reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2020 after selling out during the quarter.
Weaver Consulting Group sold 395 Teva Pharmaceutical Industries Limited shares in Q4 2020, an estimated $4K.
Weaver Consulting Group first reported a position in Teva Pharmaceutical Industries Limited in Q1 2019 and held it in 7 quarters.
Weaver Consulting Group's Teva Pharmaceutical Industries Limited position peaked at $5K in Q2 2020.
450 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2020.

Based on Weaver Consulting Group's 13F filing for Q4 2020, filed 29 Jan 2021.